Eosinophilia is characterized by more than 0.5 × 109 eosinophils per liter in the full blood count. A wide range of conditions, from asthma to parasitic infections, autoimmune diseases, and certain forms of cancer, have been known to trigger abnormally high amount of eosinophils. It is essential to reach the correct diagnosis and treat the underlying disease aggresively. Definition of the eosinophilia-myalgia syndrome was offered in 1980s by Centers for Disease Control and Prevention for surveillance purposes, and criteria were revised in 2001, with high specificity. We report a case of 59-year old female who started a special weight-reducing diet regimen that included excessive cashew nut ingestion. Several months after she has presented with periferal blood eosinophilia and constitutional symptoms. Detailed work-up has not found elements for haematological, systemic autoimmune, neoplastic or infectious disease. She was diagnosed with eosinophilia-myalgia syndrome due to extreme L-tryptophan intake, a compound found in the cashew nut’s oil. She responded well to cashew nut withdrawal and steroid therapy. In the follow-up period she remained stable with normal eosinophil count and there was not a need for any specific therapy.
 Holland SM, Gallin JI. Disorders of Granulocytes and Monocytes. In: Fauci AS et al. [ed.] Harrison’s Principles of Internal Medicine, ed. 17. New York, McGraw-Hill Companies, 2008:383 Search in Google Scholar
 Medsger, T.A. Eosinophilia-myalgia syndrome. In Medscape Reference [online]. Available at: www.emedicine.medscape.com/article/329614-overview Search in Google Scholar
 Gotlib J. Eosinophilic disorders: Molecular pathogenesis, new classification and mofern therapy. Best practice & Reasearch Clinical Haematology. 2006;19(3):535–569 http://dx.doi.org/10.1016/j.beha.2005.07.01310.1016/j.beha.2005.07.013Search in Google Scholar PubMed
 Allen J.A., Paterson A., Sufit R., et al. Postepidemic eosinophilia-myalgia syndrome associated with L-tryptopan. Arthritis & Rheumatism. 2011; 63(11) 3633–3639 http://dx.doi.org/10.1002/art.3051410.1002/art.30514Search in Google Scholar PubMed PubMed Central
 de Araujo Guerra Grangeia T, Schweller M, Aparecida Paschoal I, et al. Acute respiratory failure as a manifestation of eosinophilia-myalgia syndrome associated with L-tryptophan intake. J Bras Pulmol. 2007;33(6):747–751 http://dx.doi.org/10.1590/S1806-3713200700060002110.1590/S1806-37132007000600021Search in Google Scholar PubMed
 Noakes R, Spelman L, Williamsom R. Is the L-tryptophan metabolite quinolonic acid responsable for eosinophilic fasciitis? Clin Exp Med. 2006; 6:60–64 http://dx.doi.org/10.1007/s10238-006-0096-510.1007/s10238-006-0096-5Search in Google Scholar PubMed
 Hertzman PA, Clauw DJ, Duffy J. Rigorous new approach to constructing a gold standard for validating new diagnostic criteria, as exemplified by eosinohilia-myalgia syndrome. Ann Intern Med. 2001; 161: 2301–2306 http://dx.doi.org/10.1001/archinte.161.19.230110.1001/archinte.161.19.2301Search in Google Scholar PubMed
 Dinic-Uzurov V, Lalosevic V, Milosevic I, et al. [Current differential diagnosis of hypereosinophilic syndrome] Med Pregl. 2007:LX(11–12):581–586 http://dx.doi.org/10.2298/MPNS0712581D10.2298/MPNS0712581DSearch in Google Scholar PubMed
 Petterson R, Germolec D. Toxic Oli Syndrome: Review of immune aspects of the disease. J of Immunotoxicology. 2005;2(1):51–58 http://dx.doi.org/10.1080/1547691059096014310.1080/15476910590960143Search in Google Scholar PubMed
 Liss M. Eosinophilia. In Medscape Reference [online]. Available at: www.emedicine.medscape.com/article/199879-overview Search in Google Scholar
© 2014 Versita Warsaw
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.